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Van Schaik et al. reply: We agree that adequate and regular quality 
control of HIV test kits as well as adequate training in performing 
HIV tests are extremely important. 
HIV tests performed at the mobile clinic, community clinic and 
hospital are all rapid HIV tests, performed outside a laboratory by 
nursing staff, and are subject to the same quality control issues.
Staff working on the mobile unit are all trained in the use of the 
rapid tests and our standard operating procedures. We have our 
own quality control programme and are part of an external quality 
assurance programme run by the National Health Laboratory Service 
(NHLS), where to date we have scored 100%. In addition we have an 
informal quality control method in that we see many known HIV-
positive individuals who request re-testing. Any discrepant results 
are confirmed with laboratory HIV enzyme-linked immunosorbent 
assay (ELISA)/polymerase chain reaction (PCR).
HIV test kits are stored at temperatures of less than 30oC in our 
offices and only enough for that day’s testing are taken out on the 
mobile unit. 
For our own quality control programme, samples from known 
positive and known negative individuals (confirmed by laboratory 
HIV ELISA testing) are run with each new batch and monthly 
thereafter. The control samples must give the intended response (i.e. 
positive or negative). The staff member who performed the quality 
control procedure records the results on the rapid HIV testing quality 
control log sheet, which then gets filed. Any control problems are 
immediately reported to the project manager and acted on.
Disaster preparedness – looking 
forward
To the Editor: I refer to the article ‘Haiti: The South African 
perspective’1 in the SAMJ of August 2010.
It is timeous that the authors have opened the debate on the 
South African medical rescue response to disasters, particularly at 
home and on our continent. The problems are succintly set out, 
real and need to be addressed meaningfully and rapidly. While the 
challenges are clear, the way forward as suggested in the article is less 
so. Given the less than organised, if praiseworthy, efforts of the two 
organisations mentioned in the article, it seems to be compounding 
the issue by suggesting that the future disaster response be placed 
under the auspices of the Emergency Medicine Society of South 
Africa (EMSSA) – another non-statutory body.
South Africa, as one of the most developed countries on the 
continent, will be expected internationally to respond meaningfully 
to natural and other disasters in Africa. To be able to do this will at 
least require government approval and resource support if there is to 
be a rapid and effective deployment of medical rescue assistance.
At the end of the day, most of the material and human resources 
required either belong to or work for one or other government 
department, provincial and national, including a large number 
of volunteers. In this particular context, I believe the National 
Department of Health in conjunction with those provinces that 
possess the requisite assets, which will include departments of 
emergency medicine, should take the lead. Together they successfully 
mobilised for the 2010 Soccer World Cup – surely an African disaster 
response is no less deserving of this kind of effort.
A G Mac Mahon
Cape Town
alanjean@telkomsa.net
Schistosomiasis – an endemic but 
neglected tropical disease in Limpopo
To the Editor: After malaria, schistosomiasis is the second most 
prevalent tropical infection, but is first among the neglected tropical 
diseases (NTDs).1 Worldwide, an estimated 750 million people are 
at risk of schistosomiasis, and 200 million have the disease; 85% of 
the latter and all 20 million with severe disease are concentrated in 
Africa.2,3
We conducted a study that describes the pathology of biopsy 
diagnosed schistosomiasis, silent or symptomatic, in Limpopo 
Province to call attention on an NTD with potentially severe 
morbidity and mortality. This is especially important in view of the 
HIV/AIDS epidemic that poses a higher burden on women than 
men. Evidence is accumulating that female genital schistosomiasis 
(FGS) acts as a co-factor in the genesis of cervical pre-invasive and 
invasive lesions and/or as an entry point for the HI virus.
Over the period 2008-2009, all new cases of biopsy diagnosed 
schistosomiasis were prospectively recorded. The diagnosis was made 
in the presence of viable (embryonated) and/or non-viable (calcified) 
ova; Schistosoma haematobium in the presence of a terminal spike 
and S. mansoni if the spike was lateral.
The patients’ age, gender, geographical origin, anatomical site and 
type of lesion, if any, were recorded. There were 266 females, and 45 
males (F/M ratio 5.9/1). Table I illustrates the relative distribution 
by gender and affected organs. FGS accounted for 233 (87.6%) of 
the female cases; of the 127 cases involving the cervix, 29 (22.8%) 
were HIV-seropositive. Only 44 cases were asymptomatic, namely 
the incidentally found ova in bilateral tubal ligation (N=40) and 
prolapsed fibromyomas (N=4). In males, the appendix was the most 
common site – 30 (66.6%). The overall S. haematobium to S. mansoni 
ratio was 5.1/1. The ratio was 6.1/1 with urogenital pathology, and 
3.2/1 with digestive tract pathology. These figures show an overlap 
of the two subtypes in urogenital and digestive lesions, and an 
overall predominance of S. haematobium. Of the cases of known 
geographical origin, 91% were from the northern and north-eastern 
parts of the province bordering Zimbabwe and Mozambique.
Failure in the supply of safe water sources and sanitation, and 
failure to control snail intermediate hosts, lead to the continued 
transmission of the infection.2,4 Control interventions require 
economic progress, political will and stability, and adequate public 
health structures and programmes.2 School-based health programmes 
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Table I. Relative distribution by affected organ and gender
Organ Females (266) Males (45)
Upper genital organs*   74
Lower genital organs† 127
Perineum   32   2
Bowel   16 30
Bladder   15 10
Varia     2   3
*Uterine body, adnexae. 
†Cervix.
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are a major tool to reduce morbidity.5,6 South Africa is a signatory of 
World Health Assembly Resolution 54.19 that calls on member 
states to take effective steps to control schistosomiasis and soil-
transmitted helminthiasis. This calls for non-selective treatment of all 
children at risk, and targets the year 2010 for regular chemotherapy 
programmes.6
The importance of such preventive policies is because praziquantel 
kills the adult schistosoma but not the ova. The ova cause granulomas, 
the entry and exit for the transmission of HIV, and possibly act as a 
co-factor in cervical carcinogenesis.3
Louis-Jacques van Bogaert
National Health Laboratory Service, and 
University of Limpopo
Polokwane
Limpopo
ljfvanbo@lantic.net
GP remuneration compared with non-
health care costs
To the Editor: While working for the National Pathology Group 
(NPG) to help them understand the pathology cost trends in medical 
schemes from publicly available data, we came across two interesting 
relationships between costs in the private industry.  
Medical schemes have lamented the inflation increase in pathology 
costs over the past 5 years. This gave rise to a Discovery Health 
advertisement in a medical publication, ‘Working together we can 
ensure a strong, sustainable health care system’, where the increase in 
pathology costs was raised as a problem and doctors were requested 
to assist Discovery Medical Scheme manage these costs. In reviewing 
pathology trends against other trends within Discovery, using data 
obtained from the Council for Medical Schemes, we established the 
following.
Fig. 1 clearly shows that Discovery Medical Scheme experienced 
greater pressure in average beneficiary per annum (pabpa) trends for 
medical specialists (this measure excludes all radiology, pathology 
and anesthesiology) and general practitioners in the 5-year period 
than the scheme experienced in pathology costs. This graph supports 
the Lifechoice view that it is the increase in members accessing 
specialist care that drives pathology, radiology, hospital and other 
benefit expenditure areas.
Comparing Discovery Medical Scheme’s non-health care costs 
(NHCs) against the other South African medical schemes reveals the 
other interesting cost relationship. 
Fig. 2. shows that the NHCs of Discovery Medical Scheme, the 
biggest scheme in South Africa, are significantly higher than the 
rest of the industry excluding Discovery. The difference shown is 
more than the amount Discovery Medical Scheme pays the general 
practitioners who look after its members and what it spends on 
pathology. This cost comparison cannot be ignored.
This difference may also be seen in some other open medical 
schemes, and some argue that open medical scheme and closed 
medical scheme NHCs are not comparable (we are not convinced that 
consumers would see this argument as relevant).  
Lifechoice, together with one of South Africa’s most respected 
independent health actuaries, have researched the cost drivers in 
South African health going back to 1980. The costs of belonging to 
medical schemes have increased over 400% in real terms since 1980. 
The five most significant cost drivers seen over this period are:
1.   A lack of focus by medical schemes on primary health care.
2.    A focus on specialist curative care and the costs associated with 
this.
3.    The hospital admission and other costs that result from the focus 
on specialist care.
4.   NHCs. 
5.    Missing medical scheme legislation – the current legislation is 
only sustainable if all working South Africans are compelled 
to belong to a medical scheme (so-called mandatory cover), 
prescribed minimum benefits include primary health care 
benefits, and clarity is provided regarding exactly what is covered 
by prescribed.
We must indeed start working together to ensure sustainable 
health care. It is critical that as we do this, we focus on all of the above 
areas. Until we move towards models that support primary health 
care and fund primary health care properly, we will continue to see 
costs escalate.
Andrew Good
MD, Lifechoice
agood@lifechoice.co.za
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Fig. 1. Discovery Medical Scheme – cumulative increases per average benefi-
ciary per annum since 2005.Fig. 1. Discovery Medical Scheme 
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